Project Grant HT94252411025
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10022, USA
Similar Awards
The federal Project Grant award in the amount of $1,518,817.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, is supporting research by Weill Medical College of Cornell University to characterize 3'-UTR biology as a mechanism of therapy response in high-risk prostate cancer. The project aims to advance understanding of cellular processes involved in prostate cancer...
This $677,998 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Weill Medical College of Cornell University to target extrachromosomal DNA (ecDNA) and reverse therapy resistance in urothelial cancer. The award has a period of performance from September 1, 2024 to August 31, 2027. As a prominent academic medical institution, Weill Medical College of Cornell University has an extensive track...
This federal Project Grant award, with a total funding amount of $312,610.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research at the Weill Medical College of Cornell University focused on the "ROLE OF FUNCTIONAL FACTORS IN AR REPROGRAMMING AND PROGRESSION OF PROSTATE CANCER." This award, with a performance period from September 30, 2024 to September 29, 2026, will enable the Weill Medical...
The U.S. Defense Health Agency awarded a $1,522,278 Project Grant to Weill Medical College of Cornell University on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports a research project titled "Decoding Bone Metastasis in Prostate Cancer: A Multimodal Approach Integrating Genomics and Imaging Data." The project aims to advance scientific understanding and improve treatment of bone metastasis in prostate cancer patients...
This federal Project Grant award for $808,141.00, funded by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, is supporting research at Weill Medical College of Cornell University focused on "Targeting Inflammatory Pathways in Breast Cancer Brain Metastases for the Treatment of Edema and Radiation Necrosis Using Anti-VEGF Ultrasmall Particle Therapy." The award, with a performance period from February 1, 2025 to...
The federal Project Grant award in the amount of $878,000.00 was provided by the Defense Health Agency (DHA) under the Military Health Services Research (MHSR) Program (CFDA 12.007) to Weill Medical College of Cornell University. The grant, awarded on September 1, 2024, supports research on the impact of staffing levels on access, quality, and utilization of primary care services. The research project is set to be completed by August 31, 2026. As a prominent academic medical institution with...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $838,341.00 to the Weill Medical College of Cornell University to conduct research on "Dissecting the Role of Folate Deficiency in Lung Cancer Development and Genomic Instability." The award period runs from May 1, 2024 to April 30, 2026. The research aims to investigate the link between folate deficiency and the development...
The Department of the Army Medical Command awarded a $762,750 Project Grant to Weill Medical College of Cornell University under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research on perk-driven stress responses that regulate dendritic cell function in ovarian cancer. Through June 2024, Weill Medical College will investigate how stress responses impact immune cell activity and how this relationship influences ovarian cancer progression....
The federal Project Grant award in the amount of $847,501.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, the award is funding research at Weill Medical College of Cornell University to investigate the role of BCL-XL in breast cancer metastasis...
The Research Foundation for the State University of New York (SUNY) was awarded a $1.67 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Enhancing Renal Cell Carcinoma Immunotherapy with Neoepitope Vaccination Strategies." The three-year award, effective June 30, 2022 through June 29, 2025, will fund research to transform health care for service members and the...